Olaplex acquires biotech firm Purvala Bioscience for $10.5M in cash

OLAPLEX HOLDINGS, INC.

Purchase price $10.5M, subject to adjustments; $1.05M escrowed for 15 months for indemnification.
Purvala is a Boston biotech founded by MIT professor Dr. Bradley Olsen, focused on bioinspired molecules for health/beauty.
This is Olaplex's first acquisition since its launch over 10 years ago, signaling renewed innovation push.
Olaplex CEO Amanda Baldwin said Purvala tech could create 'next generation of disruptive science-backed product innovation'.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.